VisionCare’s FDA Approved Telescope Gets Implanted
VisionCare’s lead product, Implantable Miniature Telescope by Dr. Isaac Liphitz, enlarges images in front of the eye approximately 2.5 times their normal size.
visioncare opthalmic technologies
ThromboGenics Starts Phase II Trial for Macular Degeneration Therapy
ThromboGenics, a company specializing in biotherapeutics for vascular diseases, cancer, and eye diseases, has announced the start of a Phase II trial of microplasmin to treat age-related wet macular degeneration (AMD).